PlusORTHO Prothetik GmbH reached another significant milestone in December 2022 with its 10th anniversary within the PlusORTHO Group. This occasion primarily signifies that we are aware that we have succeeded—despite fierce competition—in establishing ourselves in the market and building up a loyal customer base.

At the end of November 2022, the Swiss Parliament voted in favor of FDA (US Food & Drug Administration) approval of US medical devices. On Monday, November 28, a motion for “more leeway in the procurement of medical devices to supply the Swiss population” was passed in the Swiss Parliament.